Lobe Sciences Ltd. (CVE:LOBE) | WebDisclosure

Basculer en Français

10353	Companies
215405	Keywords
145202	Articles
114098	Press releases

Home
Companies
Lobe Sciences Ltd.

BRIEF

published on 05/06/2026 at 12:05, 4 hours 19 minutes ago

Lobe Sciences publie ses résultats financiers et son bilan opérationnel du deuxième trimestre 2026

Résultats Financiers Placement Privé Perte Nette Investissement En R&D Développement De Médicaments
BRIEF

published on 05/06/2026 at 12:05, 4 hours 19 minutes ago

Lobe Sciences Reports Q2 2026 Financials and Operational Progress

Private Placement Financial Results Drug Development Net Loss R&D Investment
PRESS RELEASE

published on 05/06/2026 at 12:00, 4 hours 24 minutes ago

Lobe Sciences Reports Second Quarter 2026 Results and Highlights Continued Operational Progress
Lobe Sciences Ltd. released unaudited financial results for Q2 2026, showing progress in R&D expenses, operating cash flow, and net loss. CEO emphasizes advancing core programs and maintaining shareholder value

Financial Results Operating Cash Flow Net Loss R&D Expenses Lobe Sciences Ltd.
BRIEF

published on 04/23/2026 at 14:05, 13 days 2 hours ago

Lobe Sciences se félicite de la décision de la Maison Blanche concernant le développement de médicaments neurologiques

Développement De Médicaments Troubles Neurologiques Expansion De La Recherche Décret Exécutif Sciences Du Lobe
BRIEF

published on 04/23/2026 at 14:05, 13 days 2 hours ago

Lobe Sciences Welcomes White House Order on Neurological Drug Development

Drug Development Neurological Disorders Research Expansion Executive Order Lobe Sciences
PRESS RELEASE

published on 04/23/2026 at 14:00, 13 days 2 hours ago

Lobe Sciences Ltd. Comments on White House Executive Order Supporting Drug Development for Neurological and Mental Health Disorders
Lobe Sciences welcomes White House Executive Order supporting advancements in neurology and mental health treatments, focusing on scientific research and compound evaluation

Mental Health Neurology Thérapies Lobe Sciences White House Executive Order
BRIEF

published on 04/21/2026 at 12:05, 15 days 4 hours ago

Lobe Sciences Ltd. s'associe à Massive Intelligence pour ses relations avec les investisseurs.

Relations Avec Les Investisseurs Produits Biopharmaceutiques Communications D'entreprise Sciences Du Lobe Intelligence Massive
BRIEF

published on 04/21/2026 at 12:05, 15 days 4 hours ago

Lobe Sciences Ltd. Partners with Massive Intelligence for Investor Relations

Investor Relations Biopharmaceuticals Corporate Communications Lobe Sciences Massive Intelligence
PRESS RELEASE

published on 04/21/2026 at 12:00, 15 days 4 hours ago

Lobe Sciences Ltd. Engages Massive Intelligence Pty Ltd for Investor Relations and Corporate Communications Services
Lobe Sciences engages Massive Intelligence for investor relations and corporate communications services. Massive Intelligence to provide promotional services via social media, email, and press releases

Investor Relations Biopharmaceutical Corporate Communications Lobe Sciences Massive Intelligence
BRIEF

published on 04/20/2026 at 12:05, 16 days 4 hours ago

Lobe Sciences Completes Private Placement and Provides Corporate Update

Private Placement Biopharmaceutical Investment Lobe Sciences Sickle Cell Treatment S-100 Development

1 2 ... 8

Accesswire

Published on 05/06/2026 at 15:25, 59 minutes ago

Electrovaya Announces Date for Q2-2026 Financial Results & Conference Call
Published on 05/06/2026 at 15:15, 1 hour 9 minutes ago

Karbon-X Reports Increased Engagement as Canadian Facilities Reassess Compliance Exposure Ahead of Carbon Deadlines
Published on 05/06/2026 at 15:12, 1 hour 12 minutes ago

Revival Gold Announces Closing of $33 Million Brokered Private Placement
Published on 05/06/2026 at 15:00, 1 hour 24 minutes ago

Infield Minerals Announces Option Agreement for the Detroit Gold Property in Utah
Published on 05/06/2026 at 15:00, 1 hour 24 minutes ago

Vox Royalty Announces Virtual Investor Day and Q1 2026 Earnings Release Date

View all ACCESSWIRE

EQS Group

Published on 05/06/2026 at 16:05, 19 minutes ago

SwitchBot Launches the SwitchBot Standing Circulator Fan
Published on 05/06/2026 at 15:41, 42 minutes ago

The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 05/06/2026 at 15:35, 49 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 05/06/2026 at 15:35, 49 minutes ago

MUSIC ICONS: Julien's Presents a Landmark Rock and Roll Memorabilia Auction
Published on 05/06/2026 at 15:34, 49 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc

Les Echos

Published on 05/06/2026 at 14:59, 1 hour 25 minutes ago

NRJ Group - Information relative aux droits de vote au 30.04.2026 (French & English)
Published on 05/06/2026 at 11:36, 4 hours 48 minutes ago

Nombre total de droits de vote et d'actions composant le capital social
Published on 05/06/2026 at 10:09, 6 hours 15 minutes ago

Guillemot Corporation : Information regarding the total number of voting rights and shares 30/04/2026
Published on 05/06/2026 at 10:09, 6 hours 15 minutes ago

Guillemot Corporation : Informations relatives au nombre total de droits de vote et d’actions 30/04/2026
Published on 05/06/2026 at 09:09, 7 hours 15 minutes ago

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

View all LES ECHOS COMFI WIRE